Cameco Corporation (USA)  

(Public, NYSE:CCJ)   Watch this stock  
Find more results for CCJ
20.34
0.00 (0.00%)
Pre-market: 20.32 -0.02 (-0.10%)
Aug 2, 8:49AM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 16.59 - 26.45
Open     -
Vol / Avg. 500.00/1.93M
Mkt cap 8.04B
P/E 18.22
Div/yield 0.10/1.96
EPS 1.12
Shares 395.34M
Beta 1.59
Inst. own 74%
Jul 27, 2012
Q2 2012 Cameco Earnings Conference Call
Jun 5, 2012
Cameco Analyst Meeting
Jun 5, 2012
Cameco at Dahlman Rose & Co Uranium Executive Forum
May 17, 2012
Cameco at Bank of America Merrill Lynch Global Metals, Mining & Steel Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 1.86% 18.40%
Operating margin 9.54% 21.23%
EBITD margin - 31.90%
Return on average assets 0.38% 5.85%
Return on average equity 0.63% 9.37%
Employees 3,470 -
Carbon Disclosure Rating - 61/100

Address

2121-11th Street West
SASKATOON, SK S7M 1J3
Canada
+1-306-9566200 (Phone)
+1-306-9566201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha
Discussion Group - Google Finance

Description

Cameco Corporation (Cameco) is engaged in the exploration for and the development, mining, refining, conversion and fabrication of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. Cameco has a 31.6% interest in Bruce Power Limited Partnership (BPLP), which operates the four Bruce B nuclear reactors in Ontario. Cameco has three reportable segments: uranium, fuel services and electricity.

Officers and directors

Timothy S. Gitzel President, Chief Executive Officer, Director
Age: 50
Bio & Compensation - Reuters
Grant E. Isaac Chief Financial Officer, Senior Vice President
Bio & Compensation - Reuters
Robert A. Steane Chief Operating Officer, Senior Vice President
Bio & Compensation - Reuters
Kenneth A. Seitz Senior Vice President - Marketing and Business Development
Bio & Compensation - Reuters
Gary M. S. Chad QC Senior Vice-President - Governance, Law and Corporate Secretary
Bio & Compensation - Reuters
Alice Wong Senior Vice President - Corporate Services
Bio & Compensation - Reuters
Victor J. Zaleschuk Non-Executive Independent Chairman of the Board
Age: 68
Bio & Compensation - Reuters
Ian D. Bruce Director
Age: 58
Bio & Compensation - Reuters
Donald H. F. Deranger Director
Age: 56
Bio & Compensation - Reuters
Daniel Camus Independent Director
Age: 59
Bio & Compensation - Reuters